Latest Leadership Transition News

Page 10 of 73
Xenora Minerals has committed to the next stage of its Dudley Lithium Project earn-in, revealing new lithium anomalies using enhanced soil sampling techniques. Meanwhile, the company navigates a key leadership change with a new managing director appointed.
Maxwell Dee
Maxwell Dee
20 Apr 2026
Trade Window Holdings has announced the unexpected resignation of founding CEO AJ Smith due to illness, with COO Dewald van Rensburg stepping in as acting CEO. The board is currently evaluating options for a permanent replacement.
Sophie Babbage
Sophie Babbage
20 Apr 2026
Buru Energy has secured $5.3 million through a two-tranche placement to fund enhanced development of the Rafael Gas Project, following a significant uplift in project economics from new engineering insights.
Maxwell Dee
Maxwell Dee
17 Apr 2026
Neurizon Therapeutics has secured an additional A$2.7 million through a placement addressing the shortfall from its entitlement offer, lifting total proceeds to approximately A$8.5 million. This fresh capital strengthens the biotech’s balance sheet and provides financial flexibility as it advances its lead ALS drug NUZ-001 through pivotal clinical stages.
Ada Torres
Ada Torres
16 Apr 2026
Nutritional Growth Solutions has appointed director Manik Pujara as interim CEO and CFO, replacing Andrew Grover who remains as nonexecutive chair. This leadership shuffle coincides with ongoing exploration of corporate opportunities.
Victor Sage
Victor Sage
16 Apr 2026
Argent Minerals has reported a landmark 133.1m intercept averaging 72.4 g/t silver equivalent from near surface at its Kempfield Project, including a stunning visible gold assay that deepens the resource by 80 metres and underscores its polymetallic potential.
Maxwell Dee
Maxwell Dee
16 Apr 2026
Noronex completed maiden drilling programs at key uranium and copper projects while bolstering its cash position through strategic asset sales. The company also formalised a 51% stake in its Etango North uranium project and navigates a CEO transition.
Maxwell Dee
Maxwell Dee
15 Apr 2026
Noxopharm appoints its Chief Scientific Officer Dr Olivier Laczka as CEO, aiming to capitalise on recent clinical successes and expand the Sofra™ technology’s reach in autoimmune and oncology markets.
Ada Torres
Ada Torres
15 Apr 2026
Noxopharm Limited's CEO and Managing Director Dr Gisela Mautner has resigned after four years with the company, including leading a key strategic pivot. The biotech firm plans to announce her successor shortly.
Ada Torres
Ada Torres
14 Apr 2026
Universal Store Holdings has announced the retirement of long-serving CEO Alice Barbery, with George Do stepping up as her successor from November 2026. Barbery will remain engaged as a Non-Executive Director and consultant, ensuring continuity amid leadership change.
Logan Eniac
Logan Eniac
14 Apr 2026
Lithium Plus Minerals has appointed mining veteran Andrew Haythorpe as CEO, aiming to accelerate development of its flagship Lei Lithium Project. The move signals a strategic shift as Executive Chairman Dr Bin Guo steps back from daily operations.
Maxwell Dee
Maxwell Dee
13 Apr 2026
TZ Limited has raised $810,000 through a placement of 16.2 million shares at 5 cents each, with one free attaching option per share subject to shareholder approval.
Sophie Babbage
Sophie Babbage
13 Apr 2026